Cefditoren

	WikiDoc Resources for Cefditoren
Articles
Most recent articles on Cefditoren Most cited articles on Cefditoren Review articles on Cefditoren Articles on Cefditoren in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefditoren Images of Cefditoren Photos of Cefditoren Podcasts & MP3s on Cefditoren Videos on Cefditoren
Evidence Based Medicine
Cochrane Collaboration on Cefditoren Bandolier on Cefditoren TRIP on Cefditoren
Clinical Trials
Ongoing Trials on Cefditoren at Clinical Trials.gov Trial results on Cefditoren Clinical Trials on Cefditoren at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefditoren NICE Guidance on Cefditoren NHS PRODIGY Guidance FDA on Cefditoren CDC on Cefditoren
Books
Books on Cefditoren
News
Cefditoren in the news Be alerted to news on Cefditoren News trends on Cefditoren
Commentary
Blogs on Cefditoren
Definitions
Definitions of Cefditoren
Patient Resources / Community
Patient resources on Cefditoren Discussion groups on Cefditoren Patient Handouts on Cefditoren Directions to Hospitals Treating Cefditoren Risk calculators and risk factors for Cefditoren
Healthcare Provider Resources
Symptoms of Cefditoren Causes & Risk Factors for Cefditoren Diagnostic studies for Cefditoren Treatment of Cefditoren
Continuing Medical Education (CME)
CME Programs on Cefditoren
International
Cefditoren en Espanol Cefditoren en Francais
Business
Cefditoren in the Marketplace Patents on Cefditoren
Experimental / Informatics
List of terms related to Cefditoren

Cefditoren
	File:Cefditorenpivoxil.png
Identifiers
	IUPAC name (2,2-dimethylpropanoyloxymethyl (6R,7R)-7-([(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino)-3 -[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;
CAS Number	117467-28-4;
PubChem CID	6917926;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C25H28N6O7S3
Molar mass	620.721 g.mol-1

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef® by Cornerstone BioPharma.

Clinical use

Indications

Cefditoren is used to treat community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis (ABECB), pharyngitis, tonsilitis, and uncomplicated skin and skin structure infections.

Formulations

Cefditoren is available as 200 mg tablets.

trade name: Spectracef

External links

Template:WS

v t e Antibacterials: cell wall disruption (J01C-J01D)
Internal to membrane/ (inhibit peptidoglycan subunit synthesis and transport)	Template:Navbox subgroup
Glycopeptide/ (inhibit PG chain elongation)	Vancomycin # (Oritavancin, Telavancin) · Teicoplanin (Dalbavancin) · Ramoplanin
Beta-lactams/ (inhibit cross-links with PBP)	Template:Navbox subgroup
Other	Template:Navbox subgroup
# = WHO-EM

Cefditoren

Contents

Clinical use

Indications

Formulations

See also

External links

Navigation menu

Identifiers
File:Cefditorenpivoxil.png
IUPAC name (2,2-dimethylpropanoyloxymethyl (6R,7R)-7-([(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino)-3 -[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
CAS Number	117467-28-4
PubChem CID	6917926
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₅H₂₈N₆O₇S₃
Molar mass	620.721 g.mol^-1